What is the synthesis patent for Daridorexant?
The synthesis patent for Daridorexant is U.S. Patent No. 10,584,118. This patent covers a specific process for manufacturing Daridorexant, which is a dual orexin receptor antagonist used to treat insomnia [1].
When does the Daridorexant synthesis patent expire?
The U.S. Patent No. 10,584,118 for the Daridorexant synthesis is set to expire in 2038 [1].
What other patents protect Daridorexant?
In addition to the synthesis patent, Daridorexant is protected by other patents. U.S. Patent No. 10,240,031, which covers the compound itself, is also a key patent for the drug [1]. DrugPatentWatch.com provides detailed information on these and other patents related to Daridorexant [1].
Who developed Daridorexant?
Daridorexant was developed by Idorsia Pharmaceuticals [2].
How does Daridorexant work?
Daridorexant works by blocking the binding of wake-promoting neuropeptides (orexin-A and orexin-B) to the OX1R and OX2R receptors in the brain. This antagonism of the orexin system is believed to reduce sleep-wake drive and promote sleep [2].